These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 28895065)
1. Structural Characterization of the Trimerization of TRAF6 Protein Through Molecular Dynamics Simulations. Biswas R; Bagchi A Interdiscip Sci; 2019 Sep; 11(3):428-436. PubMed ID: 28895065 [TBL] [Abstract][Full Text] [Related]
3. Structure based virtual screening of natural products to disrupt the structural integrity of TRAF6 C-terminal domain homotrimer. Biswas R; Chowdhury N; Biswas S; Roy R; Bagchi A J Mol Graph Model; 2019 Dec; 93():107428. PubMed ID: 31493661 [TBL] [Abstract][Full Text] [Related]
4. E2 interaction and dimerization in the crystal structure of TRAF6. Yin Q; Lin SC; Lamothe B; Lu M; Lo YC; Hura G; Zheng L; Rich RL; Campos AD; Myszka DG; Lenardo MJ; Darnay BG; Wu H Nat Struct Mol Biol; 2009 Jun; 16(6):658-66. PubMed ID: 19465916 [TBL] [Abstract][Full Text] [Related]
5. A structural perspective on the interactions of TRAF6 and Basigin during the onset of melanoma: A molecular dynamics simulation study. Biswas R; Ghosh S; Bagchi A J Mol Recognit; 2017 Nov; 30(11):. PubMed ID: 28612997 [TBL] [Abstract][Full Text] [Related]
6. Crystal structure of TRAF1 TRAF domain and its implications in the TRAF1-mediated intracellular signaling pathway. Kim CM; Choi JY; Bhat EA; Jeong JH; Son YJ; Kim S; Park HH Sci Rep; 2016 May; 6():25526. PubMed ID: 27151821 [TBL] [Abstract][Full Text] [Related]
7. Structural basis for self-association and receptor recognition of human TRAF2. Park YC; Burkitt V; Villa AR; Tong L; Wu H Nature; 1999 Apr; 398(6727):533-8. PubMed ID: 10206649 [TBL] [Abstract][Full Text] [Related]
8. The Structure and Ubiquitin Binding Properties of TRAF RING Heterodimers. Das A; Middleton AJ; Padala P; Ledgerwood EC; Mace PD; Day CL J Mol Biol; 2021 Apr; 433(8):166844. PubMed ID: 33539883 [TBL] [Abstract][Full Text] [Related]
9. TRAF trimers form immune signalling networks via RING domain dimerization. Das A; Foglizzo M; Padala P; Zhu J; Day CL FEBS Lett; 2023 May; 597(9):1213-1224. PubMed ID: 36310378 [TBL] [Abstract][Full Text] [Related]
10. Molecular basis for the unique deubiquitinating activity of the NF-kappaB inhibitor A20. Lin SC; Chung JY; Lamothe B; Rajashankar K; Lu M; Lo YC; Lam AY; Darnay BG; Wu H J Mol Biol; 2008 Feb; 376(2):526-40. PubMed ID: 18164316 [TBL] [Abstract][Full Text] [Related]
11. Structural Characterization of TRAF6 N-Terminal for Therapeutic Uses and Computational Studies on New Derivatives. Guven O; Sever B; Başoğlu-Ünal F; Ece A; Tateishi H; Koga R; Radwan MO; Demir N; Can M; Dilsiz Aytemir M; Inoue JI; Otsuka M; Fujita M; Ciftci H; DeMirci H Pharmaceuticals (Basel); 2023 Nov; 16(11):. PubMed ID: 38004473 [TBL] [Abstract][Full Text] [Related]
12. Oligomerization-primed coiled-coil domain interaction with Ubc13 confers processivity to TRAF6 ubiquitin ligase activity. Hu L; Xu J; Xie X; Zhou Y; Tao P; Li H; Han X; Wang C; Liu J; Xu P; Neculai D; Xia Z Nat Commun; 2017 Oct; 8(1):814. PubMed ID: 28993672 [TBL] [Abstract][Full Text] [Related]
13. Molecular characterization and functional analysis of TRAF6 in orange-spotted grouper (Epinephelus coioides). Li YW; Li X; Xiao XX; Zhao F; Luo XC; Dan XM; Li AX Dev Comp Immunol; 2014 May; 44(1):217-25. PubMed ID: 24378225 [TBL] [Abstract][Full Text] [Related]
14. Siah ubiquitin ligase is structurally related to TRAF and modulates TNF-alpha signaling. Polekhina G; House CM; Traficante N; Mackay JP; Relaix F; Sassoon DA; Parker MW; Bowtell DD Nat Struct Biol; 2002 Jan; 9(1):68-75. PubMed ID: 11742346 [TBL] [Abstract][Full Text] [Related]
16. Dynamics of the RING domain from human TRAF6 by 15N NMR spectroscopy: implications for biological function. Markin CJ; Saltibus LF; Spyracopoulos L Biochemistry; 2008 Sep; 47(38):10010-7. PubMed ID: 18759459 [TBL] [Abstract][Full Text] [Related]
17. Identification and analyses of natural compounds as potential inhibitors of TRAF6-Basigin interactions in melanoma using structure-based virtual screening and molecular dynamics simulations. Biswas R; Chowdhury N; Mukherjee R; Bagchi A J Mol Graph Model; 2018 Oct; 85():281-293. PubMed ID: 30253283 [TBL] [Abstract][Full Text] [Related]
18. Distinct molecular mechanism for initiating TRAF6 signalling. Ye H; Arron JR; Lamothe B; Cirilli M; Kobayashi T; Shevde NK; Segal D; Dzivenu OK; Vologodskaia M; Yim M; Du K; Singh S; Pike JW; Darnay BG; Choi Y; Wu H Nature; 2002 Jul; 418(6896):443-7. PubMed ID: 12140561 [TBL] [Abstract][Full Text] [Related]
19. Isolation and characterization of tumor necrosis factor receptor-associated factor 6 (TRAF6) from grouper, Epinephelus tauvina. Wei J; Guo M; Gao P; Ji H; Li P; Yan Y; Qin Q Fish Shellfish Immunol; 2014 Jul; 39(1):61-8. PubMed ID: 24811008 [TBL] [Abstract][Full Text] [Related]
20. Epigallocatechin-3-gallate(EGCG) suppresses melanoma cell growth and metastasis by targeting TRAF6 activity. Zhang J; Lei Z; Huang Z; Zhang X; Zhou Y; Luo Z; Zeng W; Su J; Peng C; Chen X Oncotarget; 2016 Nov; 7(48):79557-79571. PubMed ID: 27791197 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]